Offering lower toxicity and higher accuracy than conventional therapies, this source offers illustrative coverage of this new method to treat tumors associated with brain, breast, lung, and neuroendocrine cancers. Accompanied by a CD offering color images, radiolabeling procedures, and tips on radiopharmceutical administration, this source will off

chapter 1|30 pages

Peptide Structure and Analysis

ByCarlo Pedone, Giancarlo Morelli, Diego Tesauro, Michele Saviano

chapter 2|9 pages

Radiopeptide Targeting for Tumor Therapy: Peptide Receptor Distribution

ByJean Claude Reubi

chapter 3|45 pages

Developments of Radiolabeled Peptides

ByRonald E. Weiner, Mathew L. Thakur

chapter 4|32 pages

The Labeling of Peptides with Positron-Emitting Radionuclides: The Importance of PET in Cancer Diagnosis

ByStefano Papi, Nicoletta Urbano, Esteban R. Obenaus, Marco Chinol

chapter 5|7 pages

Radiolabeling DOTA-Peptides with 90Y and 177Lu to a High Specific Activity

ByWouter A. P. Breeman, Erik de Blois, Willem H. Bakker, Eric P. Krenning

chapter 6|17 pages

Peptide Receptor Radionuclide Therapy: Preclinical Findings

ByAstrid Capello, Wouter A. P. Breeman, Bert Bernard, Marion de Jong, Eric P. Krenning

chapter 9|28 pages

Therapeutic Potential of Radiolabeled Peptides: The Basel Experience

ByChristian Waldherr, Jan Müller-Brand

chapter 10|11 pages

Somatostatin Receptor-Mediated Radionuclide Therapy for Cancer: Therapy with 90Y-DOTA-Lanreotide

ByIrene Virgolini, Tatjana Traub-Weidinger, Michael Gabriel, Dirk Heute, Margarida Rodrigues

chapter 12|5 pages

New Clinical Studies with 177Lu-Labelled Somatostatin Analogs

ByDik J. Kwekkeboom, Eric P. Krenning

chapter 13|23 pages

Radiation Dosimetry Methods for Therapy

ByMichael G. Stabin

chapter 14|37 pages

Dosimetry Applied to Peptide Radionuclide Receptor Therapy

ByMarta Cremonesi

chapter 16|8 pages

Regulatory Requirements for Therapy Trials

ByGiampiero Tosi

chapter 17|14 pages

Pretargeted Peptide Delivery with Irreversible Antibody

ByDavid A. Goodwin, Claude F. Meares